What is NDC 68001-406?

68001-406 is the product NDC for Vancomycin Hydrochloride, Vancomycin hydrochloride 5 g/1 injection, powder, lyophilized, for solution, listed with the FDA by BluePoint Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.

BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vancomycin Hydrochloride?

128 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vancomycin Hydrochloride NDC 68001-406

NDC codes

FDA NDC Directory

Product NDC (as listed)68001-406Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68001-0406Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68001-406-73	6800104067368001040673	1 VIAL, GLASS in 1 CARTON (68001-406-73) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASSMarketed from Aug 23, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vancomycin Hydrochloride
Generic name (nonproprietary): vancomycin hydrochloride
Active ingredients: Vancomycin hydrochloride — 5 g/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: BluePoint LaboratoriesNDC labeler code 68001
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204125
Marketing start: Aug 23, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Glycopeptides (Chemical structure)
Identifiers: Product ID 68001-406_e94323bb-8135-b34a-e053-2995a90a7ab8SPL ID e94323bb-8135-b34a-e053-2995a90a7ab8SPL set ID f28e3c2b-ae31-4c2a-8178-53962b7b213cRxCUI 239209, 313572UNII 71WO621TJD
Pharmacologic class: Glycopeptide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468001040673 followed by a unit qualifier and the quantity

Package 68001-0406-73. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 22, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Vancomycin Hydrochloride for Injection, USP is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (ß-lactam-resistant) staphylococci. It is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin Hydrochloride for Injection, USP is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68001-406

What is NDC 68001-406?: 68001-406 is the product NDC for Vancomycin Hydrochloride, Vancomycin hydrochloride 5 g/1 injection, powder, lyophilized, for solution, listed with the FDA by BluePoint Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vancomycin Hydrochloride.
What is the active ingredient?: Vancomycin hydrochloride.
Who is the labeler?: BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vancomycin Hydrochloride?: 128 other product NDCs are listed under this name. See all Vancomycin Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Vancomycin Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Vancomycin Hydrochloride	Vancomycin hydrochloride 5 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-957	68462-0957-05
Vancomycin Hydrochloride	Vancomycin hydrochloride 10 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-958	68462-0958-10
Vancomycin Hydrochloride	Vancomycin hydrochloride 750 mg/1	Injection, Powder, For solutionIntravenous, Oral	Avenacy, LLC	83634-114	83634-0114-20
Vancomycin Hydrochloride	Vancomycin hydrochloride 1.25 g/1	Injection, Powder, For solutionIntravenous, Oral	Avenacy, LLC	83634-115	83634-0115-30
Vancomycin Hydrochloride	Vancomycin hydrochloride 1.5 g/1	Injection, Powder, For solutionIntravenous, Oral	Avenacy, LLC	83634-116	83634-0116-30
vancomycin hydrochloride	Vancomycin hydrochloride 125 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-967	23155-0967-2523155-0967-78
vancomycin hydrochloride	Vancomycin hydrochloride 250 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-968	23155-0968-2523155-0968-78
vancomycin hydrochloride	—	Kit	Aurobindo Pharma Limited	59651-669	59651-0669-0359651-0669-55
vancomycin hydrochloride	—	Kit	Aurobindo Pharma Limited	59651-670	59651-0670-0359651-0670-55
Vancomycin Hydrochloride	Vancomycin hydrochloride 125 mg/1	CapsuleOral	PAI Holdings, LLC dba PAI Pharma	0121-1032	00121-1032-2000121-1032-50

All 129 Vancomycin Hydrochloride NDCs

Other NDCs under ANDA 204125

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204125
Product	Strength	Form · route	Labeler	Product NDC
Vancomycin Hydrochloride	Vancomycin hydrochloride 10 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi, LLC	63323-314
Vancomycin Hydrochloride	Vancomycin hydrochloride 10 g/1	Injection, Powder, Lyophilized, For solutionIntravenous	BluePoint Laboratories	68001-407